Aligos Therapeutics, Inc. (ALGS) Tops Q2 EPS by 19c

Aligos Therapeutics, Inc. (NASDAQ: ALGS) reported Q2 EPS of $0.03, $0.19 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Aligos Therapeutics, Inc. (ALGS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Nvidia said to back $100bn OpenAI data center in Ohio
• Popular stocks: MU SPCX INTC SOFI MRVL MSTR SNDK PLTR NBIS